Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Duopharma agrees to revised RM375m contract

A blockchain advantage
Share on FacebookShare on Twitter

DUOPHARMA Biotech Berhad’s wholly-owned subsidiary Duopharma Marketing Sdn Bhd (DMktg) and India’s Biocon Ltd’s local unit Biocon Sdn Bhd have accepted a revised Letter of Award (LoA) from the Ministry of Health (MoH) relating to the supply of Insugen.

It is a recombinant human insulin product developed by Biocon for the treatment of diabetes mellitus, under the MoH’s procurement by way of direct negotiation.

Under the revised LoA, the RM375.17 million contract runs for three years commencing Apr 29, 2022 until Apr 28, 2025. The previous LoA was for a period starting from Dec 17, 2021 until Dec 16, 2024.

In a filing to the stock exchange on Apr 25, Duopharma Biotech said DMktg and Biocon have acknowledged receipt and acceptance of the revised LoA. A binding contract will be created between the government, DMktg and Biocon.

Duopharma Biotech had announced in December last year that the government had accepted the tender offer from DMktg to supply the insulin product. The revised LoA will allow DMktg to provide distribution services for the supply of Biocon’s human insulin formulation to all MoH’s hospitals, district health offices and health clinics.

“With an estimated 3.9 million diabetics in Malaysia, of which about 420,000 patients are treated using human insulin in government hospitals and clinics, DMktg and Biocon hope to improve diabetes management in the country by providing high quality and cost-effective biosimilar insulins,” Duopharma Biotech said in a statement.

Duopharma Biotech was incorporated in 2000 and is one of Malaysia’s leading pharmaceutical companies listed on Bursa Malaysia.

The contract is expected to contribute positively to its future earnings for the financial years ending Dec 31, 2022, 2023, 2024 and 2025.

Tags: DuopharmaDuopharma BiotechLocal NewsThe Health 2022The Health May/June 2022theHealth
Previous Post

Fasting during Ramadan boosts health and wellbeing

Next Post

Spotlight on caregivers of diabetes patients

Live Edition Paper

JUNE 2023 ePaper

MAY 2023 ePaper

 

Subscribe for free complimentary live editions:

Recent News

  • Driving eye care and eye health standards
    January 3, 2023
    Elevating eye care and eye health standards through stakeholder collaborations […]
  • Sedania bullish on 2021 prospects
    January 1, 2021
    TECHNOLOGY company Sedania Innovator Bhd is bullish on its growth prospect next […]
  • Vaccine controversy
    January 1, 2021
    The rush to develop Covid-19 vaccines has given rise to the issue of whether it […]
  • Reszon to make Chembio’s HIV test kits
    June 29, 2022
    Partnership will see combining resources and manufacturing strengths in the […]
  • Duopharma Biotech fortifies ethical culture
    September 3, 2021
    MALAYSIA’S leading pharmaceuticals company, Duopharma Biotech Berhad announced […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist